V. Prise

发表

Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy.

Borivoj Vojnovic, B. Vojnovic, S. Ameer-Beg, 2005, Advanced drug delivery reviews.

Estimation of Apparent Tumor Vascular Permeability from Multiphoton Fluorescence Microscopic Images of P22 Rat Sarcomas In Vivo

Constantino Carlos Reyes-Aldasoro, Borivoj Vojnovic, Vincent J Cunningham, 2008, Microcirculation.

The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses.

M. Stratford, G. Tozer, V. Prise, 2002, International journal of oncology.

Nitric oxide in biological fluids: analysis of nitrite and nitrate by high-performance ion chromatography.

M. Stratford, G. Tozer, P. Wardman, 1995, Journal of chromatography. A.

Resistance to flow through tissue-isolated transplanted rat tumours located in two different sites.

D. Hirst, G. Tozer, V. Prise, 1993, British Journal of Cancer.

Characterisation of tumour blood flow using a 'tissue-isolated' preparation.

V. Cunningham, V. Cunningham, G. Tozer, 1994, British Journal of Cancer.

Evaluation of the anti‐vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI

B. Vojnovic, R. Maxwell, G. Rustin, 2002, NMR in biomedicine.

The influence of nitric oxide on tumour vascular tone.

G. Tozer, V. Prise, K. M. Bell, 1995, Acta oncologica.

Quantitative estimation of tissue blood flow rate.

V. Cunningham, G. Tozer, V. Prise, 2009, Methods in molecular biology.

A comparative study of tumour‐blood‐flow modification in two rat‐tumour systems using endothelin‐1 and angiotensin II: Influence of tumour size on angiotensin‐II response

G. Tozer, D. Chaplin, V. Prise, 1996, International journal of cancer.

Tumour blood flow modification by endothelin-related peptides in the rat HSN fibrosarcoma.

G. Tozer, D. Chaplin, V. Prise, 1996, The British journal of cancer. Supplement.

The modification of blood flow in tumours and their supplying arteries by nicotinamide.

D. Hirst, G. Tozer, E. Flitney, 1995, Acta oncologica.

Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes

Francisco J. López, J. Glenn, Alan W. Stitt, 2016, Proceedings of the National Academy of Sciences.

The effects of pentoxifylline on the relative perfusion of tumours growing in three sites in the mouse.

D. Hirst, V. Prise, P. L. Sensky, 1993, British Journal of Cancer.

Changes in tumour morphology with alterations in oxygen availability: further evidence for oxygen as a limiting substrate.

D. Hirst, V. Hirst, V. Prise, 1991, British Journal of Cancer.

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

G. Tozer, D. Chaplin, S. Hill, 1997, Cancer research.

Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors.

Christiana Ruhrberg, Chryso Kanthou, Constantino C Reyes-Aldasoro, 2008, Cancer research.

Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.

B Vojnovic, G M Tozer, M Cemazar, 2001, Cancer research.

Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.

B Vojnovic, G M Tozer, B. Vojnovic, 1999, Cancer research.

Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.

G. Tozer, D. Chaplin, V. Prise, 1997, Cancer research.

Quantitative Estimation of Tissue Blood Flow Rate.

V. Cunningham, G. Tozer, V. Prise, 2016, Methods in molecular biology.

The influence of vasoactive agents on the perfusion of tumours growing in three sites in the mouse.

D. Hirst, V. Hirst, V. Prise, 1991, International journal of radiation biology.

Tumour vascular disrupting agents: combating treatment resistance.

G M Tozer, C. Kanthou, B. Vojnovic, 2008, The British journal of radiology.

Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer

P. Wilson, M. LaBonte, R. Ladner, 2021, npj Breast Cancer.

Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer

P. Wilson, M. LaBonte, R. Ladner, 2021, NPJ breast cancer.

Heme Oxygenase and the Novel Tumour-Specific Anti-Vascular Compound Combretastatin A4-Phosphate

C. Kanthou, G. Tozer, R. Foresti, 2002 .

Modification of blood flow in the HSN tumour and normal tissues of the rat by the endothelin ETB receptor agonist, IRL 1620

G. Tozer, D. Chaplin, V. Prise, 1999, International journal of cancer.

Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses

G. Tozer, S. Hill, V. Prise, 2009, Clinical Cancer Research.

Influence of soluble or matrix‐bound isoforms of vascular endothelial growth factor‐A on tumor response to vascular‐targeted strategies

Meit A. Bjorndahl, C. Kanthou, C. Reyes-Aldasoro, 2013, International journal of cancer.

The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification

G. Tozer, M. Čemažar, S. Hill, 2005, British Journal of Cancer.

Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification.

M. Stratford, G. Tozer, D. Chaplin, 1996, British Journal of Cancer.

Effect of Endothelin‐1 and Sarafotoxin S6c on Blood Flow in a Rat Tumor

G. Tozer, D. Chaplin, V. Prise, 1995, Journal of cardiovascular pharmacology.

Effects of Tin-Protoporphyrin IX on Blood Flow in a Rat Tumor Model

G. Tozer, V. Prise, A. Khelifi, 2003, Experimental biology and medicine.

The comparative effects of the NOS inhibitor, Nomega-nitro-L-arginine, and the haemoxygenase inhibitor, zinc protoporphyrin IX, on tumour blood flow.

G. Tozer, D. Chaplin, R. Motterlini, 1998, International journal of radiation oncology, biology, physics.

Spatial heterogeneity of tumour blood flow modification induced by angiotensin II: Relationship to receptor distribution

G. Tozer, V. Prise, K. Bell, 1996, International journal of cancer.

Vascular response of tumour and normal tissues to endothelin‐1 following antagonism of ETA and ETB receptors in anaesthetised rats

G. Tozer, D. Chaplin, V. Prise, 1997, International journal of cancer.